Editorial
doi: 10.2217/fon-2020-0989.
Epub 2021 Jan 29.
DNA damage response alterations in gastric cancer: knocking down a new wall
Affiliations
- PMID: 33508962
- DOI: 10.2217/fon-2020-0989
Item in Clipboard
Editorial
DNA damage response alterations in gastric cancer: knocking down a new wall
Future Oncol.
2021 Mar.
No abstract available
Keywords: ARID1; ATM; BRCA; DDR alteration; PARP inhibitor; gastric cancer.
Similar articles
-
PARP inhibitors in gastric cancer: beacon of hope.J Exp Clin Cancer Res. 2021 Jun 24;40(1):211. doi: 10.1186/s13046-021-02005-6. J Exp Clin Cancer Res. 2021. PMID: 34167572 Free PMC article. Review.
-
The DNA Damaging Revolution: PARP Inhibitors and Beyond.Am Soc Clin Oncol Educ Book. 2019 Jan;39:185-195. doi: 10.1200/EDBK_238473. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099635 Review.
-
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3. J Clin Oncol. 2019. PMID: 31050911 Review.
-
Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency.Oncol Rep. 2018 Jul;40(1):479-487. doi: 10.3892/or.2018.6445. Epub 2018 May 16. Oncol Rep. 2018. PMID: 29767248
-
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.J Exp Clin Cancer Res. 2018 Jun 28;37(1):129. doi: 10.1186/s13046-018-0790-7. J Exp Clin Cancer Res. 2018. PMID: 29954437 Free PMC article.
Cited by
-
Comparative assessment of the capability of machine learning-based radiomic models for predicting omental metastasis in locally advanced gastric cancer.Sci Rep. 2024 Jul 13;14(1):16208. doi: 10.1038/s41598-024-66979-x. Sci Rep. 2024. PMID: 39003337 Free PMC article.
-
Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis.World J Gastrointest Oncol. 2023 Dec 15;15(12):2212-2224. doi: 10.4251/wjgo.v15.i12.2212. World J Gastrointest Oncol. 2023. PMID: 38173439 Free PMC article.
-
A Case of Long-Term Survival with Recurrent Liver Metastases from Gastric Cancer Treated with Nivolumab.Case Rep Oncol. 2024 Mar 7;17(1):438-446. doi: 10.1159/000537779. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 38455714 Free PMC article.
-
The persistent risk of secondary malignancies in gastric neuroendocrine tumor survivors: a population-based analysis.Clin Exp Med. 2025 May 14;25(1):158. doi: 10.1007/s10238-025-01706-y. Clin Exp Med. 2025. PMID: 40366428 Free PMC article.
-
Efficacy and safety of different drugs in patients with HER2-positive gastric cancer: network meta-analysis.Syst Rev. 2025 Feb 10;14(1):40. doi: 10.1186/s13643-025-02777-4. Syst Rev. 2025. PMID: 39930467 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
